College of Agriculture & Natural Resources

Permanent URI for this communityhttp://hdl.handle.net/1903/1598

The collections in this community comprise faculty research works, as well as graduate theses and dissertations.

Browse

Author: search.filters.author.Padmanabhan, Rangarajan

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    MOLECULAR MECHANISMS UNDERLYING CADHERIN-6B INTERNALIZATION IN PREMIGRATORY CRANIAL NEURAL CREST CELLS DURING THEIR EPITHELIAL-TO-MESENCHYMAL TRANSITION
    (2015) Padmanabhan, Rangarajan; Taneyhill, Lisa A; Animal Sciences; Digital Repository at the University of Maryland; University of Maryland (College Park, Md.)
    The generation of migratory cells from immotile precursors occurs frequently throughout development and is crucial to the formation and maintenance of a functioning organism. This phenomenon, called an epithelial-to-mesenchymal transition (EMT), involves the disassembly of intercellular adhesions and cytoskeletal rearrangements in order to promote migration. Importantly, aberrant EMTs and cell migration can lead to devastating human conditions including cancer metastasis and fibrosis. How cells accomplish EMT to become migratory is still an unanswered question in the biomedical field. To this end, we use chick neural crest cells as an in vivo model to elucidate the molecules and pathways that regulate EMT and migration. Neural crest cells are a population of embryonic cells that are originally stationary within the dorsal neural tube but later migrate to form a variety of adult derivatives, such as the craniofacial skeleton, skin pigment cells and portions of the heart. To facilitate EMT, chick premigratory neural crest cells lose intercellular contacts mediated, in part, by the transmembrane cell adhesion protein Cadherin-6B (Cad6B). While Cad6B mRNA is transcriptionally repressed in premigratory neural crest cells, loss of Cad6B protein does not directly follow and instead occurs ~90 minutes later, just prior to migration. This rapid depletion of Cad6B is all the more striking given that the half-life of most cadherins, including Cad6B, is ~6-8 hours in vitro. As such, unique post- translational mechanisms must exist to remove Cad6B from premigratory neural crest cell plasma membranes to facilitate neural crest EMT. Since cadherins are known to be downregulated through internalization mechanisms (e.g., endocytosis, macropinocytosis) in other in vitro systems, the hypothesis of this dissertation is that Cad6B is internalized, and that this process plays a critical function to enable neural crest EMT. To this end, we document the existence of Cad6B cytoplasmic puncta in cultured cells, cultured neural crest cells and transverse sections of chick embryos. We subsequently identified a p120-catenin binding motif in the Cad6B cytoplasmic tail and demonstrated its functionality through site-directed mutagenesis, revealing a role in enhancing Cad6B internalization and reducing the stability of membrane-bound Cad6B. Furthermore, we uncover for the first time that Cad6B is removed from premigratory cranial neural crest cells through cell surface internalization events that include clathrin-mediated endocytosis and macropinocytosis. Both of these processes are dependent upon the function of dynamin, and inhibition of Cad6B internalization abrogates neural crest cell EMT and migration. Collectively, our findings provide a molecular blueprint for how cadherins are dynamically regulated during the formation of migratory cell types required for normal embryonic development and tissue repair as well as those generated during human diseases and cancers. Importantly, our research is multi-disciplinary, integrating cell biology and physiology to reveal how a cellular event, the active downregulation of a membrane protein, results in a physiological event, neural crest EMT and migration.
  • Thumbnail Image
    Item
    Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses
    (2011-01-21) Cai, Yibin; Song, Haichen; Ye, Jianqiang; Shao, Hongxia; Padmanabhan, Rangarajan; Sutton, Troy C; Perez, Daniel R
    Mass in ovo vaccination with live attenuated viruses is widely used in the poultry industry to protect against various infectious diseases. The worldwide outbreaks of low pathogenic and highly pathogenic avian influenza highlight the pressing need for the development of similar mass vaccination strategies against avian influenza viruses. We have previously shown that a genetically modified live attenuated avian influenza virus (LAIV) was amenable for in ovo vaccination and provided optimal protection against H5 HPAI viruses. However, in ovo vaccination against other subtypes resulted in poor hatchability and, therefore, seemed impractical. In this study, we modified the H7 and H9 hemagglutinin (HA) proteins by substituting the amino acids at the cleavage site for those found in the H6 HA subtype. We found that with this modification, a single dose in ovo vaccination of 18- day old eggs provided complete protection against homologous challenge with low pathogenic virus in ≥70% of chickens at 2 or 6 weeks post-hatching. Further, inoculation of 19-day old egg embryos with 10 6 EID50 of LAIVs improved hatchability to ≥90% (equivalent to unvaccinated controls) with similar levels of protection. Our findings indicate that the strategy of modifying the HA cleavage site combined with the LAIV backbone could be used for in ovo vaccination against avian influenza. Importantly, with protection conferred as early as 2 weeks post-hatching, with this strategy birds would be protected prior to or at the time of delivery to a farm or commercial operation.